Literature DB >> 35400011

Predictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Chika Mizutani1, Nobuhisa Matsuhashi1, Hiroyuki Tomita2, Takao Takahashi1, Tomonari Suetsugu1, Jesse Yu Tajima1, Shigeru Kiyama1, Itaru Yasufuku1, Yoshihiro Tanaka1, Naoki Okumura1, Katsutoshi Murase1, Manabu Futamura3, Masaya Kawaguchi4, Takuma Ishihara5, Masayuki Matsuo4, Tatsuhiko Miyazaki6, Akira Hara2, Kazuhiro Yoshida1.   

Abstract

Background/Aim: Prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) indicate nutritional status and host immunity. We used immunohistochemistry and apparent diffusion coefficient (ADC) values calculated using diffusion-weighted imaging (DWI) to investigate relationships of these factors with pathological and radiological characteristics in rectal cancer treated with neoadjuvant chemoradiotherapy (nCRT). Patients and
Methods: We evaluated expression levels of VEGFA, CD8, CD33, and ADC values in tumors pre/post nCRT; and analyzed the relationships between those factors and PNI, NLR in 32 patients.
Results: Pretreatment PNI negatively correlated with change in tumor stromal CD8 + T cells and positively correlated with ADC values. Pretreatment NLR and PNI change correlated with recurrence-free survival (RFS).
Conclusion: Patients with higher pretreatment PNI had greater changes in ADC values and stromal CD8 + T-cell counts, and those with greater PNI reduction from nCRT had a worse prognosis. Proper nutritional management during nCRT benefits patients and may lead to better prognosis in rectal cancer. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Colorectal cancer; VEGFA; apparent diffusion coefficient; neoadjuvant chemotherapy; neutrophil-to-lymphocyte ratio; prognostic nutritional index; tumorinfiltrating lymphocytes

Year:  2022        PMID: 35400011      PMCID: PMC8962848          DOI: 10.21873/cdp.10074

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  47 in total

1.  Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness.

Authors:  Luís Curvo-Semedo; Doenja M J Lambregts; Monique Maas; Geerard L Beets; Filipe Caseiro-Alves; Regina G H Beets-Tan
Journal:  J Magn Reson Imaging       Date:  2012-01-23       Impact factor: 4.813

2.  Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.

Authors:  Lotte Jacobs; Martijn Intven; Niels van Lelyveld; Marielle Philippens; Maarten Burbach; Kees Seldenrijk; Maartje Los; Onne Reerink
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

3.  Prognostic nutritional index in gastrointestinal surgery.

Authors:  G P Buzby; J L Mullen; D C Matthews; C L Hobbs; E F Rosato
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

4.  The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma.

Authors:  Tadahiro Nozoe; Mayuko Kohno; Tomohiro Iguchi; Emiko Mori; Takashi Maeda; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-12-03       Impact factor: 2.549

5.  Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.

Authors:  Bénédicte F Jordan; Pierre Sonveaux
Journal:  Front Pharmacol       Date:  2012-05-21       Impact factor: 5.810

6.  Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximab.

Authors:  Feng Wang; Long Bai; Tian-Shu Liu; Yi-Yi Yu; Ming-Ming He; Kai-Yan Liu; Hui-Yan Luo; Dong-Sheng Zhang; Yin Jin; Feng-Hua Wang; Zhi-Qiang Wang; De-Shen Wang; Miao-Zhen Qiu; Chao Ren; Yu-Hong Li; Rui-Hua Xu
Journal:  Chin J Cancer       Date:  2015-06-10

7.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Authors:  Yojiro Hashiguchi; Kei Muro; Yutaka Saito; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Kiyoshi Hasegawa; Kinichi Hotta; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Yusuke Kinugasa; Keiko Murofushi; Takako Eguchi Nakajima; Shiro Oka; Toshiaki Tanaka; Hiroya Taniguchi; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Takeharu Yamanaka; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Michio Itabashi; Kentaro Sakamaki; Keiji Sano; Yasuhiro Shimada; Shinji Tanaka; Hiroyuki Uetake; Shigeki Yamaguchi; Naohiko Yamaguchi; Hirotoshi Kobayashi; Keiji Matsuda; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2019-06-15       Impact factor: 3.402

8.  Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status.

Authors:  Been-Ren Lin; Yu-Lin Lin; Hong-Shiee Lai; Po-Huang Lee; King-Jen Chang; Jin-Tung Liang
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma.

Authors:  Xiao-Han Yuan; Jie Yang; Xin-Yue Wang; Xiao-Ling Zhang; Ting-Ting Qin; Kai Li
Journal:  Oncol Lett       Date:  2018-06-05       Impact factor: 2.967

10.  The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype.

Authors:  Philipp Mayer; Alica Linnebacher; Hannah Glennemeier-Marke; Nicole Marnet; Frank Bergmann; Thilo Hackert; Miriam Klauss; Tanja Poth; Matthias M Gaida
Journal:  Int J Mol Sci       Date:  2020-01-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.